Warning: The NCBI web site requires JavaScript to function. more...
Expression of the epidermal growth factor receptor (EGFR) and the phosphorylated EGFR in invasive breast carcinomas.
Magkou C, Nakopoulou L, Zoubouli C, Karali K, Theohari I, Bakarakos P, Giannopoulou I.
Breast Cancer Res. 2008;10(3):R49. Epub 2008 Jun 3.
Related citations
Clinicopathological and prognostic significance of vascular endothelial growth factors (VEGF)-C and -D and VEGF receptor 3 in invasive breast carcinoma.
Mylona E, Alexandrou P, Mpakali A, Giannopoulou I, Liapis G, Markaki S, Keramopoulos A, Nakopoulou L.
Eur J Surg Oncol. 2007 Apr;33(3):294-300. Epub 2006 Nov 28.
Expression patterns and predictive value of phosphorylated AKT in early-stage breast cancer.
Andre F, Nahta R, Conforti R, Boulet T, Aziz M, Yuan LX, Meslin F, Spielmann M, Tomasic G, Pusztai L, Hortobagyi GN, Michiels S, Delaloge S, Esteva FJ.
Ann Oncol. 2008 Feb;19(2):315-20. Epub 2007 Sep 5.
Flt-4-positive vessel density correlates with vascular endothelial growth factor-d expression, nodal status, and prognosis in breast cancer.
Nakamura Y, Yasuoka H, Tsujimoto M, Yang Q, Imabun S, Nakahara M, Nakao K, Nakamura M, Mori I, Kakudo K.
Clin Cancer Res. 2003 Nov 1;9(14):5313-7.
[Correlation of epidermal growth factor receptor activation to metastasis-free survival of nasopharyngeal carcinoma patients].
Yuan TZ, Li XX, Cao Y, Qian CN, Zeng MS, Guo X.
Ai Zheng. 2008 May;27(5):449-54. Chinese.
Expression of epidermal growth factor receptor (EGFR) and activated EGFR predict poor response to (chemo)radiation and survival in cervical cancer.
Noordhuis MG, Eijsink JJ, Ten Hoor KA, Roossink F, Hollema H, Arts HJ, Pras E, Maduro JH, Reyners AK, de Bock GH, Wisman GB, Schuuring E, van der Zee AG.
Clin Cancer Res. 2009 Dec 1;15(23):7389-97. Epub 2009 Nov 17.
[Activation and prognostic significance of AKT, NF-kappaB and STAT3 in breast cancer with lymph node metastasis and estrogen receptor expression].
Liu C, Zhou S, Ke CS, Li NP, Wu RL.
Ai Zheng. 2007 Sep;26(9):929-36. Chinese.
Matrix metalloproteinase 9 and the epidermal growth factor signal pathway in operable non-small cell lung cancer.
Cox G, Jones JL, O'Byrne KJ.
Clin Cancer Res. 2000 Jun;6(6):2349-55.
Macrophage infiltration is associated with VEGF and EGFR expression in breast cancer.
Leek RD, Hunt NC, Landers RJ, Lewis CE, Royds JA, Harris AL.
J Pathol. 2000 Mar;190(4):430-6.
Study of the topographic distribution of ets-1 protein expression in invasive breast carcinomas in relation to tumor phenotype.
Mylona EE, Alexandrou PT, Giannopoulou IA, Rafailidis PI, Markaki S, Keramopoulos A, Nakopoulou LL.
Cancer Detect Prev. 2006;30(2):111-7. Epub 2006 May 2.
Expression of amphiregulin and epidermal growth factor receptor in human breast cancer: analysis of autocriny and stromal-epithelial interactions.
Ma L, de Roquancourt A, Bertheau P, Chevret S, Millot G, Sastre-Garau X, Espié M, Marty M, Janin A, Calvo F.
J Pathol. 2001 Aug;194(4):413-9.
Phosphorylation, but not overexpression, of epidermal growth factor receptor is associated with poor prognosis of non-small cell lung cancer patients.
Kanematsu T, Yano S, Uehara H, Bando Y, Sone S.
Oncol Res. 2003;13(5):289-98.
Clinical impact of phosphorylated signal transducer and activator of transcription 3, epidermal growth factor receptor, p53, and vascular endothelial growth factor receptor 1 expression in resected adenocarcinoma of lung by using tissue microarray.
Kim HS, Park YH, Lee J, Ahn JS, Kim J, Shim YM, Kim JH, Park K, Han J, Ahn MJ.
Cancer. 2010 Feb 1;116(3):676-85.
Upregulation of basic fibroblast growth factor in breast carcinoma and its relationship to vascular density, oestrogen receptor, epidermal growth factor receptor and survival.
Smith K, Fox SB, Whitehouse R, Taylor M, Greenall M, Clarke J, Harris AL.
Ann Oncol. 1999 Jun;10(6):707-13.
An immunohistochemical evaluation of phosphorylated Akt at threonine 308 [pAkt(Thr308)] in invasive breast cancer.
Magkou C, Mylona E, Theohari I, Giannopoulou I, Papanikolaou E, Markaki S, Nakopoulou L.
In Vivo. 2007 Nov-Dec;21(6):967-72.
Coexpression of epidermal growth factor receptor with related factors is associated with a poor prognosis in non-small-cell lung cancer.
Swinson DE, Cox G, O'Byrne KJ.
Br J Cancer. 2004 Oct 4;91(7):1301-7.
[Epidermal growth factor receptor and phosphorylated Akt protein expression in non-small-cell lung cancer].
Zhou ZL, Yang F, Jiang GC, Huang YQ, Fu J, Wang J.
Zhonghua Yi Xue Za Zhi. 2008 Apr 15;88(15):1062-5. Chinese.
Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis.
Pellikainen JM, Ropponen KM, Kataja VV, Kellokoski JK, Eskelinen MJ, Kosma VM.
Clin Cancer Res. 2004 Nov 15;10(22):7621-8.
Prognostic significance of c-erbB-2/neu amplification and epidermal growth factor receptor (EGFR) in primary breast cancer and their relation to estradiol receptor (ER) status.
Torregrosa D, Bolufer P, Lluch A, López JA, Barragán E, Ruiz A, Guillem V, Munárriz B, García Conde J.
Clin Chim Acta. 1997 Jun 27;262(1-2):99-119.
Comparison of the prognosis indication of VEGFR-1 and VEGFR-2 and Tie2 receptor expression in breast carcinoma.
Meunier-Carpentier S, Dales JP, Djemli A, Garcia S, Bonnier P, Andrac-Meyer L, Lavaut MN, Allasia C, Charpin C.
Int J Oncol. 2005 Apr;26(4):977-84.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on